Indie Asset Partners, LLC Royalty Pharma PLC Transaction History

Indie Asset Partners, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$32.77 - $39.4 $950,330 - $1.14 Million	-29,000 Reduced 6.28%	433,000 $15.6 Million
Q4 2022 Feb 01, 2023	SELL	$39.17 - $44.04 $2.34 Million - $2.63 Million	-59,750 Reduced 11.45%	462,000 $18.3 Million
Q3 2022 Oct 25, 2022	SELL	$39.88 - $44.65 $1.99 Million - $2.23 Million	-49,838 Reduced 8.72%	521,750 $21 Million
Q2 2022 Aug 12, 2022	SELL	$37.53 - $44.22 $6.95 Million - $8.19 Million	-185,286 Reduced 24.48%	571,588 $24 Million
Q1 2022 May 10, 2022	SELL	$37.46 - $42.44 $1.84 Million - $2.08 Million	-49,108 Reduced 6.09%	756,874 $29.5 Million
Q4 2021 Feb 11, 2022	BUY	$35.17 - $42.48 $3.68 Million - $4.45 Million	104,659 Added 14.92%	805,982 $32.1 Million
Q3 2021 Nov 09, 2021	SELL	$36.14 - $42.24 $372,242 - $435,072	-10,300 Reduced 1.45%	701,323 $25.3 Million
Q2 2021 Aug 11, 2021	BUY	$39.85 - $46.63 $27.7 Million - $32.4 Million	695,600 Added 4341.26%	711,623 $29.2 Million
Q1 2021 May 13, 2021	SELL	$42.34 - $52.82 $156,446 - $195,169	-3,695 Reduced 18.74%	16,023 $699,000
Q4 2020 Feb 09, 2021	SELL	$36.12 - $50.05 $128,948 - $178,678	-3,570 Reduced 15.33%	19,718 $987,000
Q3 2020 Nov 13, 2020	BUY	$38.56 - $48.36 $538,297 - $675,105	13,960 Added 149.66%	23,288 $980,000
Q2 2020 Aug 12, 2020	BUY	$44.5 - $52.11 $415,096 - $486,082	9,328 New	9,328 $427,000

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Indie Asset Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Indie Asset Partners, LLC with notifications on news.